These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35510183)

  • 1. A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism.
    Lage-Rupprecht V; Schultz B; Dick J; Namysl M; Zaliani A; Gebel S; Pless O; Reinshagen J; Ellinger B; Ebeling C; Esser A; Jacobs M; Claussen C; Hofmann-Apitius M
    Patterns (N Y); 2022 Mar; 3(3):100433. PubMed ID: 35510183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
    Xu Y; Kong J; Hu P
    Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease.
    Padhi D; Govindaraju T
    J Med Chem; 2022 May; 65(10):7088-7105. PubMed ID: 35559617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.
    Grabowska ME; Huang A; Wen Z; Li B; Wei WQ
    Front Pharmacol; 2023; 14():1257700. PubMed ID: 37745051
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum.
    Gobom J; Benedet AL; Mattsson-Carlgren N; Montoliu-Gaya L; Schultz N; Ashton NJ; Janelidze S; Servaes S; Sauer M; Pascoal TA; Karikari TK; Lantero-Rodriguez J; Brinkmalm G; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Mol Neurodegener; 2022 Dec; 17(1):81. PubMed ID: 36510321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative target mining stratagems to navigate drug repurposing endeavours.
    Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
    Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph-Based Approach.
    Lou P; Fang A; Zhao W; Yao K; Yang Y; Hu J
    J Med Internet Res; 2023 Oct; 25():e45225. PubMed ID: 37862061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors.
    Phatak SS; Zhang S
    Pac Symp Biocomput; 2013; ():29-40. PubMed ID: 23424109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates.
    Cartas-Cejudo P; Cortés A; Lachén-Montes M; Anaya-Cubero E; Puerta E; Solas M; Fernández-Irigoyen J; Santamaría E
    Brain Pathol; 2024 Jul; 34(4):e13252. PubMed ID: 38454090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
    Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
    Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
    G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
    Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.